231 related articles for article (PubMed ID: 30084408)
21. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
Richter SS; Heilmann KP; Beekmann SE; Miller NJ; Miller AL; Rice CL; Doern CD; Reid SD; Doern GV
Clin Infect Dis; 2005 Sep; 41(5):599-608. PubMed ID: 16080080
[TBL] [Abstract][Full Text] [Related]
22. [The genetic features of drug resistance to group A streptococcus and macrolides antibiotics among pediatric patients in Beijing 2012].
Peng XM; Yang P; Liu S; Li J; Zhang DT; Liu YM; Liang HJ; Cui SJ; Wu SS; Wang QY
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Nov; 47(11):1040-4. PubMed ID: 24507235
[TBL] [Abstract][Full Text] [Related]
23. Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.
Dundar D; Sayan M; Tamer GS
Microb Drug Resist; 2010 Dec; 16(4):279-84. PubMed ID: 20624096
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Pérez-Trallero E; Martín-Herrero JE; Mazón A; García-Delafuente C; Robles P; Iriarte V; Dal-Ré R; García-de-Lomas J;
Antimicrob Agents Chemother; 2010 Jul; 54(7):2953-9. PubMed ID: 20439616
[TBL] [Abstract][Full Text] [Related]
25. [Investigation of macrolide-lincosamide-streptogramin B (MLS(B)) and telithromycin resistance in clinical strains of staphylococci].
Saribaş Z; Tunçkanat F; Ozçakir O; Ercis S
Mikrobiyol Bul; 2010 Apr; 44(2):177-86. PubMed ID: 20549951
[TBL] [Abstract][Full Text] [Related]
26. Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.
Green M; Martin JM; Barbadora KA; Beall B; Wald ER
Antimicrob Agents Chemother; 2004 Feb; 48(2):473-6. PubMed ID: 14742197
[TBL] [Abstract][Full Text] [Related]
27. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
28. Inducible clindamycin resistance in β-hemolytic streptococci and Streptococcus pneumoniae.
Megged O; Assous M; Weinberg G; Schlesinger Y
Isr Med Assoc J; 2013 Jan; 15(1):27-30. PubMed ID: 23484235
[TBL] [Abstract][Full Text] [Related]
29. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
[TBL] [Abstract][Full Text] [Related]
31. Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.
Billal DS; Hotomi M; Yamauchi K; Fujihara K; Tamura S; Kuki K; Sugita R; Endou M; Mukaigawa J; Yamanaka N
J Infect Chemother; 2004 Apr; 10(2):115-20. PubMed ID: 15160306
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae.
Nakamura PA; Schuab RB; Neves FP; Pereira CF; Paula GR; Barros RR
Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):119-22. PubMed ID: 21537668
[TBL] [Abstract][Full Text] [Related]
33. Macrolide resistance phenotypes and mechanisms of resistance in Streptococcus pyogenes in La Rioja, Spain.
Portillo A; Lantero M; Gastañares MJ; Ruiz-Larrea F; Torres C
Int J Antimicrob Agents; 1999 Oct; 13(2):137-40. PubMed ID: 10595574
[TBL] [Abstract][Full Text] [Related]
34. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
Gherardi G; Petrelli D; Di Luca MC; Pimentel de Araujo F; Bernaschi P; Repetto A; Bellesi J; Vitali LA
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1797-802. PubMed ID: 26024763
[TBL] [Abstract][Full Text] [Related]
35. Throat Carriage Rate and Antimicrobial Resistance of
Delpech G; Sparo M; Baldaccini B; Pourcel G; Lissarrague S; García Allende L
J Prev Med Public Health; 2017 Mar; 50(2):127-132. PubMed ID: 28372355
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
[TBL] [Abstract][Full Text] [Related]
37. Decrease in macrolide resistance and clonal instability among Streptococcus pyogenes in Portugal.
Silva-Costa C; Pinto FR; Ramirez M; Melo-Cristino J;
Clin Microbiol Infect; 2008 Dec; 14(12):1152-9. PubMed ID: 19046174
[TBL] [Abstract][Full Text] [Related]
38. Macrolide and lincosamide resistance of Streptococcus agalactiae in pregnant women in Poland.
Kamińska D; Ratajczak M; Nowak-Malczewska DM; Karolak JA; Kwaśniewski M; Szumala-Kakol A; Dlugaszewska J; Gajecka M
Sci Rep; 2024 Feb; 14(1):3877. PubMed ID: 38366099
[TBL] [Abstract][Full Text] [Related]
39. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand.
Malbruny B; Werno AM; Anderson TP; Murdoch DR; Leclercq R
J Antimicrob Chemother; 2004 Dec; 54(6):1040-4. PubMed ID: 15537693
[TBL] [Abstract][Full Text] [Related]
40. Changes in Macrolide Resistance Among Group A Streptococci in Serbia and Clonal Evolution of Resistant Isolates.
Gajic I; Mijac V; Ranin L; Grego E; Kekic D; Jegorovic B; Smitran A; Popovic S; Opavski N
Microb Drug Resist; 2018 Nov; 24(9):1326-1332. PubMed ID: 29653480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
